Literature DB >> 11918944

Interferon alfa-2a for melanoma metastases.

John M Kirkwood, Joseph G Ibrahim, Vernon K Sondak, Marc S Ernstoff, Merrick Ross.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11918944     DOI： 10.1016/S0140-6736(02)08001-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  The antitumor effects of IFN-alpha are abrogated in a STAT1-deficient mouse.

Authors:  Gregory B Lesinski; Mirela Anghelina; Jason Zimmerer; Timothy Bakalakos; Brian Badgwell; Robin Parihar; Yan Hu; Brian Becknell; Gerard Abood; Abhik Ray Chaudhury; Cynthia Magro; Joan Durbin; William E Carson
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

2.  Preparation of bioactive interferon alpha-loaded polysaccharide nanoparticles using a new approach of temperature-induced water phase/water-phase emulsion.

Authors:  Guang Liu; Dong Xu; Mier Jiang; Weien Yuan
Journal:  Int J Nanomedicine       Date:  2012-09-07

Review 3.  Adjuvant therapy of melanoma with interferon: lessons of the past decade.

Authors:  Paolo A Ascierto; John M Kirkwood
Journal:  J Transl Med       Date:  2008-10-27       Impact factor: 5.531

4.  Regression of nevi in a melanoma patient treated with interferon.

Authors:  Ayelet Rishpon; Nir Nathanson
Journal:  Dermatol Pract Concept       Date:  2012-04-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.